# NHS Framework for the North of England, Branded Medicine

> Contract award record from UK public-sector procurement sources.

## Key facts

- Public buyer: [NHS England](/buyers/nhs-england/contract-awards)
- Contract winner: [Thornton and Ross Ltd](/contract-winners/thornton-and-ross/public-sector-contract-awards)
- Award value: £238,913,892
- Tender value: £431,836,170
- Award date: 7 February 2022
- Published: 8 August 2023
- Contract start: 1 March 2022
- Contract end: 29 February 2024
- Stage: awarded
- Procurement category: goods
- Notice ID: 521ac6ee-777d-4ac4-8c5c-88045d5101fd-670252
- OCID: ocds-b5fd17-8f156716-6a74-476b-ac41-29b32bb73599

## Description

Offer reference number: CM/PHR/20/5600 CM/PHR/20/5600/01 - NHS Framework for the North of England, Branded Medicines -Tranche B - 1 March 2022 to 29 February 2024 with an option or options to extend \(at the Authority's discretion\) for a period or periods up to a total of 24 months CM/PHR/20/5600/02 - NHS Framework for the North of England, Branded Medicines - Annual Tranche Products\. Period of framework: 1 March 2022 to 28 February 2023 with an option or options to extend \(at the Authority's discretion\) for a period or periods up to a total of 12 months\. CM/PHR/20/5600/03- NHS Framework for Insulin Aspart Biosimilar \(Trurapi®\), South of England - Period of framework: 1 March 2022 to 31 August 2022 with an option or options to extend \(at the Authority's discretion\) for a period or periods up to a total of 12 months\. CM/PHR/20/5600/04 - NHS Framework for Insulin Aspart Biosimilar \(Trurapi®\), London - Period of framework: 1 March 2022 to 31 August 2023 with an option or options to extend \(at the Authority's discretion\) for a period or periods up to a total of 24 months\. CM/PHR/20/5600/05 - NHS Framework for Insulin Aspart Biosimilar \(Trurapi®\), Midlands and East - Period of framework: 1 March 2022 to 28 February 2023 with an option or options to extend \(at the Authority's discretion\) for a period or periods up to a total of 24 months\.

## Related contract awards

- [Social Media Monitoring and Listening Tool 2025/26](/contracts/ocds-b5fd17-f7a9f527-0921-4f52-938b-47c2caf51a76): NHS England
- [Adult Screening and Personalisation Digital Delivery Services](/contracts/ocds-b5fd17-e39e63c3-cb93-443c-9d87-dfccd29235fa): NHS England
- [Finance Transformation & Enablement Project Support](/contracts/ocds-b5fd17-3607e706-33f0-41c5-b40f-d42e32d91957): NHS England
- [NHS National Framework for Transition products commencing 1 October 2024](/contracts/ocds-b5fd17-fb0aeb89-2056-4b82-a415-3842e6b7e9c0): NHS England
- [NHS London Branded Medicines - Tranche B - September 2023](/contracts/ocds-b5fd17-1b053612-ac3a-4f54-94e9-20ce45ce8a49): NHS England
- [NHS Framework Agreement for Branded medicines - National](/contracts/ocds-b5fd17-f7e5581c-3416-4790-902f-48bbb0fb5223): NHS England

## Source

[View the original notice on Contracts Finder](https://www.contractsfinder.service.gov.uk/Notice/521ac6ee-777d-4ac4-8c5c-88045d5101fd-670252)